Oryzon will receive approximately 0.8M USD for further development of its epigenetic inhibitors against inflammatory indications. This grant will cover the partial funding of a project entitled “Epigenetic regulation of the inflammatory response” that is currently being carried out under the leadership of Oryzon in collaboration with various well renowned academic institutions such as the Cajal Institute , the Lopez Neira Institute , Bosch i Gimpera Foundation and the Autonomous University of Barcelona.